- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
By 
Kyle Brasseur2024-02-14T21:21:00
In his first public speech as head of the U.K. Serious Fraud Office (SFO), Nick Ephgrave made clear his law enforcement background will lead to significant changes in how the agency handles its cases.
“Under my leadership, the SFO will be bolder, more pragmatic, more proactive,” said Ephgrave on Tuesday in remarks delivered at the Royal United Services Institute in London. “… We need to be bolder and explore new ways of doing things.”
Ephgrave joined the SFO at the end of September, succeeding Lisa Osofsky. His predecessor’s tenure was marred by controversy, including the failure to secure the prosecutions of several large companies and their directors (e.g., Tesco, G4S) and follow established legal procedure in key cases (e.g., Serco, Unaoil).
THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.
News and analysis for the well-informed compliance or audit exec. Select an option and click continue.
Annual Membership $499 Value offer
Full price one year membership with auto-renewal.
Membership $599
One-year only, no auto-renewal.
Discrimination against whistleblowers in the U.K. has risen to such a level that the government may need to actively pursue plans to afford greater legal protection, as well as introduce financial awards to compensate for their “career suicide.”
Nearly all but a tiny minority of financial institutions saw their costs of financial crime compliance rise in 2023, a survey by LexisNexis and Oxford Economics found.
The U.K. Serious Fraud Office last month published its five-year strategic plan outlining how it intends to improve information gathering and international cooperation, as well as its enforcement record.
USAA Federal Savings Bank has been hit with its third cease and desist order from the Treasury Department’s Office of the Comptroller of the Currency in the past five years for failing to correct unsafe and unsound banking practices.
Becton Dickinson medical device company will pay $175 million for “repeatedly” misleading investors about its Alaris infusion pump, a product the company knew was flawed and was sold without the required patient-safety approvals, the Securities and Exchange Commission said.
The Securities and Exchange Commission charged bankrupt fashion retailer Express with failing to disclose nearly $1 million in perks to a former chief executive, but did not levy a financial penalty thanks to its cooperation, the SEC said.
